Zimbabwe has turned down a major American healthcare agreement worth $367m (£272m) spanning five years because of Washington's request for sensitive biological samples.
This move came to light following a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa deemed the arrangement was "unbalanced".
An official spokesman later explained that the United States was demanding access to genetic material for scientific study and commercial purposes while refused to share the resulting advantages from future treatments.
"We must now begin the difficult and regrettable process of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had provided more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for further dialogue to reach a deal acceptable to all parties so the country's critical HIV treatment initiative can proceed.
Broader Background
Zimbabwe's decision comes after a comparable situation in Kenya, where a court halted a similar health funding agreement following legal challenges were filed about the safety of citizens' medical information.
After resuming office last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had overseen assistance for the US government, but Trump stated its expenditure was "wasteful" and his government was seeking government-to-government deals to enhance openness and accountability.
As per statements, 16 African countries have to date agreed to similar agreements, representing over $18.3bn in new funding.
Specifics of the Rejected Agreement
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation could have provided immense benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment via US-supported programmes," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, without any equivalent assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"Put simply, our country would provide the raw materials for scientific discovery without any assurance that the resulting innovations would be accessible to our citizens should a future health crisis emerge."
Sovereignty and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting frameworks previously established via the global organization.
The spokesperson cited its Pandemic Benefit-Sharing system created to deal with potential pandemics.
"This framework is intended to guarantee that when a country contributes its data, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to develop them."
These objections over the US deal "are not meant as anti-American sentiment," he added.
"We welcome further dialogue with our American counterparts on how future collaboration could be arranged in a way that respects the independence and dignity of both nations."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the official position, but suggested that negotiations need to persist considering much of the country's HIV programmes were funded by international support.
"Where technical issues arise, including those involving data governance or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," it commented.
This impasse emphasises the continuing challenges between accepting vital foreign assistance and protecting local interests in an ever more interconnected world.